Driving regulatory compliance, quality assurance and improvement
19 May 2026
GGi is collaborating with Tendable to host a series of free, in-person workshops this summer for those on quality committees. Our CEO Professor Andrew Corbett-Nolan explores why these unique learning opportunities are important to attend
Points raised in this article:
- NHS quality committees play a crucial role in covering the five key areas assessed by the Care Quality Commission
- Examples of strong and weaker practice drawn from CQC findings
- Some best-practice principles for quality committees
- How digital platforms like Tendable's transform committee impact
Quality committees play a pivotal role in the governance of NHS providers. Typically chaired by a non-executive director (NED) and reporting directly to the board, these committees provide independent oversight of clinical quality, patient safety, patient experience and related governance arrangements. They assure the board that services are safe, effective, caring, responsive and well-led: the five key questions used by the Care Quality Commission (CQC).
In an era of heightened regulatory scrutiny, financial pressures and rising public expectations, an effective quality committee is not a regulatory formality but a strategic asset that protects patients, supports staff and safeguards organisational reputation. However, a high-functioning quality committees is an essential pre-requisite for high regulatory rating.
To help understand how the quality committee is so essential for high ratings this article explores why quality committees matter, primarily with the CQC but also with other frameworks and accreditations such as Joint Advisory Group (JAG) endoscopy accreditation.
I will draw on CQC inspection findings to highlight examples of strong and weaker practice, identify best-practice principles and examine the critical role of data. In anticipation of our series of in-person workshops with our colleagues at Tendable, particular attention is given to how digital tools can equip committees with the real-time, evidence-based insights they need to discharge their responsibilities effectively. I will also highlight the value of external developmental reviews, such as those undertaken by GGi, in strengthening quality committee effectiveness.
The regulatory landscape: CQC and beyond
The CQC’s Single Assessment Framework places heavy emphasis on governance under the ‘well-led’ key question and Regulation 17 (Good Governance). Inspectors assess whether providers have clear lines of accountability, robust systems for monitoring quality and effective escalation and assurance processes.
Quality committees sit at the heart of this: they receive, scrutinise and triangulate information from across the organisation before providing assurance (or escalation) to the board.
CQC reports repeatedly link strong governance structures, including active quality committees, to ‘good’ or ‘outstanding’ well-led ratings. Conversely, weaknesses in committee oversight often contribute to ‘requires improvement’ or ‘inadequate’ ratings, sometimes triggering regulatory action.
Beyond CQC, quality committees support compliance with other requirements. NHS England expects boards to maintain effective quality governance. For specialist services, accreditations such as JAG (for gastrointestinal endoscopy units) demand documented evidence of regular audit review, learning from incidents and governance oversight.
JAG guidance explicitly requires minutes of endoscopy users’ or governance meetings to demonstrate that audits have been completed, reviewed and acted upon, with complications and safety data discussed at committee level. Similar expectations apply to other accreditations and standards (e.g., NICE guidelines and HTA licensing where relevant). A well-functioning quality committee therefore provides a single, coherent forum for pulling together these strands of evidence.
What CQC reports reveal: good and poor examples
CQC inspection reports offer rich, real-world illustrations of quality committee performance.
Positive examples demonstrate clear accountability, effective subgroup support and data-driven oversight. At Bradford Teaching Hospitals NHS Foundation Trust, the quality committee was explicitly accountable for quality-of-care governance and was supported by dedicated sub-groups covering patient experience, safety, clinical outcomes, safeguarding and mortality. CQC inspectors observed committee meetings and noted that papers contained appropriate information, enabling constructive challenge.
Highgate Hospital (independent sector) maintained an effective system for regularly assessing and monitoring service quality through its quality governance committee. This contributed to positive findings on governance and monitoring.
St George’s University Hospitals NHS Foundation Trust used its quality committee to oversee implementation of recommendations from an external quality governance review, demonstrating proactive board-level follow-through. Monthly clinical governance and quality committee meetings at services such as Midland Metropolitan University Hospital included multi-directorate representation and presented quality and safety data in structured reports.
Weaker examples highlight common pitfalls. In some trusts, quality committees have been criticised for becoming a ‘hopper for everything’, overloaded with items but lacking depth of scrutiny or triangulation. One trust was advised to bolster governance after serious incidents because it failed to triangulate information from different sources to form a coherent view of risks.
At one London trust, while governance structures existed, CQC found that some serious matters were not escalated through board sub-committees in a timely manner and that governance arrangements required strengthening in partnership settings.
Broader CQC thematic reviews and well-led inspections frequently cite failures to ensure information reported upwards is ‘reliable and of sufficient quality to lead change’. Complaints data, incident trends, and audit outcomes are sometimes presented in lengthy narrative form without clear metrics, benchmarking, or evidence of impact. This leaves committees unable to provide robust assurance or spot emerging risks.
These contrasts are not abstract. CQC’s own guidance and reviews of its operational effectiveness underscore that robust governance structures with quality committees are a prerequisite for sustainable high-quality care.
Best-practice principles for quality committees
Drawing on CQC findings, GGi insights and our experience from the many quality governance reviews we have undertaken, effective quality committees typically exhibit the following characteristics:
- Clear purpose and manageable remit: terms of reference focused on quality and safety (not diluted by operational or financial matters that belong elsewhere). Regular deep-dive sessions rather than information overload.
- Independent challenge: NEDs provide constructive scrutiny. Executive members present data transparently, and committees test assumptions rather than rubber-stamping reports.
- Triangulation of evidence: quality committees insist on cross-referencing multiple data sources (incidents, complaints, audits, patient feedback, staff surveys, outcomes, and national benchmarks) to validate assurance.
- Action-focused reporting: papers include not just what happened, but what was done, the impact achieved, and residual risks. Dashboards and exception reporting replace lengthy narratives.
- Linkage to the board assurance framework (BAF): risks rated 12–25 (or equivalent) are regularly reviewed, with clear escalation routes.
- Learning and improvement culture: committees champion quality improvement methodology, celebrate successes, and ensure learning from incidents is embedded organisation wide.
- Board visibility and escalation: formal processes ensure key issues reach the full board promptly, with evidence of committee impact.
- Diversity of insight: inclusion of staff, patient, and lived-experience voices where appropriate, alongside clinical and operational leaders.
These principles align directly with CQC’s expectations under ‘governance, management and sustainability’.
An external perspective: developmental well-led reviews and quality governance reviews
In addition to internal oversight and CQC inspections, external developmental well-led reviews and targeted quality governance reviews provide valuable independent assurance and developmental support for quality committees. GGi specialises in these reviews, which explicitly examine the functioning of quality committees within the broader governance framework.
GGi’s developmental well-led reviews assess how effectively quality committees provide assurance to the board on clinical quality, safety and patient experience. These reviews evaluate the committee’s ability to challenge, triangulate evidence and drive improvement in line with the well-led framework.
Similarly, GGi’s dedicated quality governance reviews focus specifically on the structures, processes and culture that underpin quality oversight, including the quality committee’s role in risk escalation and embedding organisational learning.
A distinctive and particularly effective feature of GGi’s methodology is the use of maturity matrices. These tools deliver a graduated, evidence-based assessment of quality committee functioning across multiple dimensions, such as clarity of purpose and remit, quality and triangulation of data, depth of challenge and scrutiny, escalation processes and linkage to quality improvement initiatives. Rather than offering a binary judgement, the maturity matrix provides a nuanced picture of current performance (for example, progressing from foundational to mature and embedded levels) while simultaneously setting out a clear, prioritised developmental improvement agenda. This approach enables committees and boards to track progress objectively over time, identify realistic targets and demonstrate a proactive commitment to continuous enhancement. This all directly supports CQC expectations for sustainable, proactive governance.
Such external reviews help organisations identify blind spots that internal processes might overlook and support boards in fulfilling their oversight duties more robustly, ultimately strengthening regulatory compliance and care quality.
The data challenge: how committees use (or fail to use) evidence
A recurring theme in CQC reports is the quality and usability of data presented to committees. Strong committees receive timely, accurate and triangulated information that enables them to identify trends, test assurance and drive improvement. Weaker ones rely on incomplete, unverified or siloed data, leading to false reassurance or delayed action.
Common failures include:
- over-reliance on self-reported or narrative updates without supporting metrics or evidence
- lack of triangulation (e.g., not linking incident data with complaints, audit results, and patient experience)
- poor data quality or timeliness, making it impossible to spot outliers or benchmark performance
- absence of trend analysis or ward/service-level granularity
- failure to close the loop on actions—issues are discussed but not evidenced as resolved.
By contrast, effective committees use data to ask the right questions: “What does this trend tell us about underlying systems? Have we seen similar issues elsewhere? What evidence shows sustainable improvement?”
How digital platforms like Tendable transform committee impact
Modern quality committees need tools that deliver real-time, verifiable and frontline-sourced data rather than retrospective paper-based reports. Tendable, a digital quality assurance platform widely used across the NHS, exemplifies how technology can bridge this gap.
Tendable’s mobile app enables frontline staff to conduct structured audits and inspections in real time, capturing photos, raising actions and logging findings instantly. The desktop portal then provides leadership with live dashboards, trend analysis, compliance scores, and ward-level insights. Key benefits for quality committees include:
- real-time assurance: historic and current compliance data can be presented to demonstrate improvement trajectories (e.g., Royal Free London NHS Foundation Trust achieved substantial gains in key audit areas through structured self-inspection processes)
- evidence for regulators: auditable trails, photo evidence, and action-completion rates provide tangible proof of compliance with CQC standards and accreditations such as JAG
- triangulation at scale: integration of audit data with incidents, patient feedback, and other sources creates a single source of truth
- board-level reporting: in Wales Cardiff and Vale University Health Board used Tendable to introduce formal board-reporting processes and real-time risk escalation
- culture change: by empowering staff and reducing administrative burden, Tendable helps shift quality from a top-down compliance exercise to a lived organisational value (as seen in case studies from Wirral University Teaching Hospital and Barnsley Hospital NHS FT).
For JAG accreditation, Tendable’s audit functionality directly supports the requirement for regular, documented review of environment, safety, and clinical standards, with minutes and evidence readily available. The same applies to CQC’s focus on continuous monitoring under Regulation 17.
In short, platforms like Tendable give quality committees the data they need to move from reactive oversight to proactive, evidence-based leadership.
Conclusion and recommendations
Quality committees are indispensable to regulatory compliance and high-quality care in NHS providers. CQC reports show that where committees are purposeful, data-driven and action-oriented organisations achieve stronger well-led ratings and sustainable improvement. Where they are overloaded, under-resourced or data-poor risks go unaddressed and regulatory outcomes suffer.
External developmental well-led and quality governance reviews, particularly those employing maturity matrices—further enhance committee effectiveness by providing objective, developmental insight and a structured improvement pathway.
To maximise impact, NHS providers should:
- ensure quality committees have clear, focused terms of reference and sufficient NED independence
- mandate triangulation and exception-based reporting using reliable, real-time data
- invest in digital tools such as Tendable to capture frontline evidence and generate actionable dashboards
- commission periodic external developmental reviews to benchmark and strengthen governance arrangements
- regularly benchmark committee effectiveness against CQC expectations and peer examples. GGi maturity matrices can help with this
- link committee work explicitly to JAG and other accreditations through shared governance processes.
In the increasingly complex regulatory environment of 2026, a strong quality committee, supported by robust data, modern technology and periodic external developmental scrutiny, is one of the best investments an NHS provider can make. It protects patients, reassures the board, satisfies regulators, and, most importantly, drives the continuous improvement that defines excellent care.
GGi invites colleagues on quality committees to join us at one of our upcoming in-person summer workshops. These are free and an excellent opportunity to network with colleagues from other quality committees and explore ideas and best practice.